Competition is working, even as the FTC meddles in a takeover fight in a way that helped Pfizer.

Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn ...

Pfizer ($PFE) has reached a deal to buy Metsera ($MTSR), a weight-loss drug startup, in a transaction that could total more ...

Novo Nordisk navigates competition and guidance challenges with strong profitability and upcoming oral Wegovy opportunities.

The weight loss drug company was counted out far too early in the summer, but investors are warming to it again.

Get the latest stock market update and key takeaways in healthcare, including Pfizer, Amgen, Novo Nordisk results, and obesity drug bidding wars.

Pfizer Inc. agreed to buy Metsera Inc. for up to $10 billion, prevailing over Novo Nordisk A/S in a tumultuous bidding war ...

The Danish pharmaceutical giant is confronting one of its most severe crises in recent memory. A perfect storm of unfavorable ...

Thinkcarebelieve: Week 42 Of America's Climb Into The Golden Age. Link to Week 42 Article: WASHINGTON, Nov. 08, 2025 (GLOBE NEWSWIRE) -- ThinkCareBelieve has published an article on Week 42 of America ...

In a transformative development for the pharmaceutical industry, Eli Lilly announced on November 6, 2025, a groundbreaking arrangement with the U.S. governme ...

The companies announced a huge deal that will have implications for investors. Eli Lilly ( LLY 1.39%) and Novo Nordisk ( NVO ...